Amrize (AMRZ) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
12 Mar, 2026Executive summary
The proxy filing covers the 2026 Annual General Meeting, including agenda items, voting procedures, and key proposals for shareholder approval.
The company completed its spin-off from Holcim in June 2025, establishing itself as an independent, publicly traded entity focused on North America.
The Board and management emphasize disciplined capital allocation, operational efficiency, and sustainable growth, with a focus on innovation and ESG initiatives.
Voting matters and shareholder proposals
Shareholders will vote on approval of the 2025 Annual Report, consolidated and statutory financial statements, and discharge of Board and management from liability.
Advisory votes include executive compensation (say-on-pay), frequency of say-on-pay, Swiss statutory remuneration report, and the Non-Financial Matters Report.
Proposals include offsetting accumulated losses, special and regular distributions from capital contribution reserves (USD 0.44 per share), and re-election/election of Board members and auditors.
Shareholders will also vote on maximum aggregate compensation for the Board (USD 3.6 million) and Executive Management (USD 59 million) for upcoming periods.
Board of directors and corporate governance
The Board is composed of a majority of independent directors, with robust governance practices aligned with NYSE and Swiss standards.
Eleven directors are proposed for election, including two new nominees, with detailed biographies and skills matrices provided.
Board committees (Audit, Compensation, Nomination & Governance) are fully independent and oversee key areas such as risk, compensation, and succession planning.
Shareholder rights include the ability to propose agenda items and director nominees, subject to shareholding thresholds.
Latest events from Amrize
- AGM to address board elections, executive pay, distributions, and non-financial reporting.AMRZ
Proxy Filing12 Mar 2026 - 2026 AGM proxy covers financials, compensation, board elections, and strong governance initiatives.AMRZ
Proxy Filing27 Feb 2026 - 2026 guidance targets 4–6% revenue and 8–11% EBITDA growth, with strong shareholder returns.AMRZ
Q4 202518 Feb 2026 - Stable Q2 2025 results and synergy program support strong outlook and long-term growth.AMRZ
Q2 202523 Nov 2025 - Q3 revenue up 6.6% to $3,675M, net income $543M, 2025 guidance raised to $12.0B.AMRZ
Q3 202529 Oct 2025